# A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults

> **NCT06659250** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 63 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-06414300
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06659250
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-27
- **Primary completion:** 2025-08-22
- **Final completion:** 2025-08-22
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06659250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06659250, "A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06659250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*